Clinical Trials Logo

Ventilator Associated Pneumonia clinical trials

View clinical trials related to Ventilator Associated Pneumonia.

Filter by:

NCT ID: NCT04527276 Completed - Clinical trials for Ventilator Associated Pneumonia

Reducing the Incidence of VAP in Critically Ill Children and Assessment of Oral Care With CHX

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This was a single-centered, randomized, placebo-controlled double-blind clinical trial conducted in the pediatric intensive care unit (PICU), in patients who were aged 1 month to 18 years, needing MV for at least 48 hours, to evaluate the effect of Chlorhexidine (CHX) on Ventilator-associated pneumonia (VAP) incidence and to determine VAP risk factors.

NCT ID: NCT04505202 Completed - Clinical trials for Ventilator Associated Pneumonia

Effect of Chlorhexidine-Induced Oral Care on Ventilator-Related Some Respiratory System Complications

Start date: April 15, 2019
Phase: N/A
Study type: Interventional

Ventilator-associated pneumonia and ventilator-associated treakeabronchitis in respiratory tract infections associated with ventilator are common infections in intensive care unit and cause significant morbidity, mortality and health expenditures in nosocomial infections. Adequate and effective oral care by nurses in intensive care patients, possible complications, intensive care unit stay in the intensive care unit and is very important in terms of mortality.

NCT ID: NCT04467892 Completed - Clinical trials for Ventilator Associated Pneumonia

Low Versus High Corticosteroid Use in Ventilator Associated Pneumonia

Start date: January 2, 2018
Phase: Phase 2
Study type: Interventional

patients who had >3 on Murray score and >6 on CPIS allocated randomly in two groups 120 patients in each. Group A received 30 mg/kg methyl-prednisolone slowly intravenous in 250 mL normal saline every 8 hours for only 48 hours while group B received 1 mg/kg/day methyl-prednisolone divided to three doses given every 8 hours for two weeks. Duration of the study last 16 days, Morbidity considered if no improvement in any or all clinical parameters of both Murray and CPIS scores and failure of weaning of patients from the ventilator at the studied period.

NCT ID: NCT04402359 Completed - Clinical trials for Ventilator Associated Pneumonia

Usage of Meropenem/Gentamicin Versus Ceftazidime/Avibactam in ARDS

Start date: July 5, 2018
Phase:
Study type: Observational [Patient Registry]

This was a prospective double blind study conducted on 200 polytrauma patients admitted to King Abdul-Aziz Specialized Hospital, Taif, KSA between July 2018 and December 2019 in surgical ICU. All patients were having severe chest trauma, contused lungs either with or without severe head trauma.

NCT ID: NCT04397952 Completed - Clinical trials for Ventilator Associated Pneumonia

Endotracheal Tube Cuff Pressure Measurement

Start date: November 1, 2017
Phase:
Study type: Observational [Patient Registry]

The effect of endotracheal cuff pressure measurement technique for preventing ventilatory associated pneumonia.

NCT ID: NCT04242706 Completed - Clinical trials for Ventilator-associated Pneumonia

VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs

VITAL
Start date: October 31, 2018
Phase: Phase 4
Study type: Interventional

The study objective is to determine VAP (Ventilator Associated Pneumonia) baseline incidence in the ICU in patients receiving endotracheal tubes with evacuation lumen with and without Bactiguard coating. The study is randomized, prospective, controlled and blinded. All adult patients hospitalized in the ICUs from two tertiary hospitals (i.e.: Centre Hospitalier Universitaire Sart Tilman Liège , Centre Hospitalier Chrétien de Liège) and considered to be ventilated for more than 24 hours will be eligible to participate in the study.

NCT ID: NCT04097899 Completed - Clinical trials for Ventilator Associated Pneumonia

Antimicrobial Stewardship Program and Ventilator Associated Pneumonia

Start date: July 1, 2016
Phase:
Study type: Observational

Antibiotic Stewardship Programs (ASPs) help clinicians improve the quality of patient care and improve patient safety through increased infection cure rates, reduced treatment failures; however, there are different techniques, with variable results, of its application including what is called ASPs bundle and there is a need to investigate the effectiveness of implementing a comprehensive care bundle program including the key components of ASPs and the key items of infection control measures, this program can be called Antimicrobial Stewardship Comprehensive Care Bundle Program (ASCCBP).

NCT ID: NCT04061083 Completed - Clinical trials for Mechanical Ventilation Complication

Effects of Endotracheal Tube Cuff Pressure Control on Microaspiration of Gastric Contents

Start date: May 16, 2019
Phase: N/A
Study type: Interventional

The purpose of study is to determine effects of three different ET cuff pressure control on microaspiration of the stomach contents.

NCT ID: NCT03982667 Completed - Clinical trials for Ventilator Associated Pneumonia

Research Title: Efficacy and Safety of Point- Of-care Procalcitonin Test to Reduce Antibiotic Exposure in VAP

Start date: June 15, 2019
Phase: N/A
Study type: Interventional

Several studies have shown that PCT guidance can reduce the duration of antibiotic treatment for patients with bacterial infections in the ICU, without compromising the safety outcomes. However PCT is known to be more costly than standard biomarkers that commonly use in our ICU setup. This remain the main challenge for us whether by monitoring the PCT level, it can reduce both the duration of antibiotic simultaneously reduce the total cost of the treatment for the patients. A local study addressing efficacy, safety and cost analysis of PCT-guided antibiotic therapy in severe pneumonia patients is therefore warranted. Until the results from a local study become available, the utility of PCT to guide antibiotic duration in our patient population cannot be recommended.

NCT ID: NCT03917888 Completed - Clinical trials for Ventilator Associated Pneumonia

Clinical Impact of Lung Ultrasound Monitoring for Diagnosis of VAP

Start date: September 10, 2017
Phase: N/A
Study type: Interventional

The study evaluates whether lung ultrasound monitoring could lead to earlier detection of ventilator associated pneumonia and influence outcome. Half of the participants will be diagnosed with VAP using a combination of lung ultrasound and clinical features and half will be diagnosed using the Johanson criteria, which is a combination of clinical features and chest x-ray.